ANIXA BIOSCIENCES INC (ANIX) vs Cognition Therapeutics, Inc. (CGTX)

ANIXA BIOSCIENCES INC and Cognition Therapeutics, Inc. are both Biotechnology companies. ANIXA BIOSCIENCES INC and Cognition Therapeutics, Inc. are of similar size ($96.6M and $90.7M). Across the 8 metrics below, ANIXA BIOSCIENCES INC leads on 4 and Cognition Therapeutics, Inc. on 4.

Valuation

Metric ANIX CGTX Biotechnology median
P/E n/m n/m 7.88
P/S 97.76 n/m 11.47
P/B 7.20 2.58 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 85.36 n/m 10.73
Earnings yield (11.51%) (18.09%) (28.84%)
Free cash flow yield (7.73%) (20.77%) (23.03%)

Profitability

Metric ANIX CGTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (72.57%) (83.76%) (57.72%)
Return on assets (63.45%) (57.33%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANIX CGTX Biotechnology median
Revenue growth (TTM) (34.10%) — 5.64%
EPS growth (last fiscal year) 12.82% 62.79% —
Revenue growth, 5-year CAGR (6.89%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX CGTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.55 7.03 4.73
Net debt to EBITDA 1.29 0.78 0.96

Dividend

Metric ANIX CGTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANIX CGTX Biotechnology median
Market cap 96.64m 90.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack